M

Monash University | Eastern Clinical Research Unit - Endocrinology

Research site
(Unclaimed)
Location
Level 2 5 Arnold St, Box Hill, Victoria, Australia
Site insights

Top conditions

Diabetes Mellitus (2 trials)

Obesity (2 trials)

Type 2 Diabetes Mellitus (2 trials)

Overweight (2 trials)

Chronic Renal Insufficiency (1 trial)

Top treatments

BI 456906
BI 690517
Pegcetacoplan
Empagliflozin

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

3 of 5
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
A Study to Test Whether Survodutide (BI 456906) Helps People Living With Overweight or Obesity Who Also Have Diabetes to Lose Weight (SYNCHRONIZE™-2)

This study is open to adults who are at least 18 years old and have a body mass index of 27 kg/m² or more. People can take part if they have type 2 d...

Enrolling
Obesity
Diabetes Mellitus, Type 2
Drug: Survodutide
Drug: Placebo

This study is open to adults who are at least 18 years old and havea body mass index (BMI) of 30 kg/m² or more, ora BMI of 27 kg/m² or more and at le...

Active, not recruiting
Obesity
Drug: Placebo
Drug: survodutide

This is a Phase 3 study to assess the efficacy and safety of twice-weekly subcutaneous (SC) doses of pegcetacoplan compared to placebo in patients wi...

Active, not recruiting
Membranoproliferative Glomerulonephritis (MPGN)
Membranoproliferative Glomerulonephritis
Other: Placebo
Drug: Pegcetacoplan

Trial sponsors

Boehringer Ingelheim logo

Boehringer Ingelheim (4 trials)

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems